Literature DB >> 24486772

A novel missense mutation in CACNA1A evaluated by in silico protein modeling is associated with non-episodic spinocerebellar ataxia with slow progression.

Katrin Bürk1, Frank J Kaiser2, Stephanie Tennstedt3, Ludger Schöls4, Friedmar R Kreuz5, Thomas Wieland6, Tim M Strom7, Thomas Büttner8, Ronja Hollstein2, Diana Braunholz2, Jens Plaschke5, Gabriele Gillessen-Kaesbach2, Christine Zühlke9.   

Abstract

Spinocerebellar ataxia type 6 (SCA6), episodic ataxia type 2 (EA2) and familial hemiplegic migraine type 1 (FHM1) are allelic disorders of the gene CACNA1A encoding the P/Q subunit of a voltage gated calcium channel. While SCA6 is related to repeat expansions affecting the C-terminal part of the protein, EA2 and FHM phenotypes are usually associated with nonsense and missense mutations leading to impaired channel properties. In three unrelated families with dominant cerebellar ataxia, symptoms cosegregated with CACNA1A missense mutations of evolutionary highly conserved amino acids (exchanges p.E668K, p.R583Q and p.D302N). To evaluate pathogenic effects, in silico, protein modeling analyses were performed which indicate structural alterations of the novel mutation p.E668K within the homologous domain 2 affecting CACNA1A protein function. The phenotype is characterised by a very slowly progressive ataxia, while ataxic episodes or migraine are uncommon. These findings enlarge the phenotypic spectrum of CACNA1A mutations.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CACNA1A; EA2; FHM1; Ion channel gene defects; Molecule dynamic simulation; SCA6; Spinocerebellar ataxia

Mesh:

Substances:

Year:  2014        PMID: 24486772     DOI: 10.1016/j.ejmg.2014.01.005

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  8 in total

Review 1.  The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.

Authors:  Stefan Kipfer; Michael Strupp
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

2.  Migraine genetics: current findings and future lines of research.

Authors:  A M Persico; M Verdecchia; V Pinzone; V Guidetti
Journal:  Neurogenetics       Date:  2014-12-14       Impact factor: 2.660

Review 3.  Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.

Authors:  Sherry-Ann Brown; Leslie M Loew
Journal:  Front Neurosci       Date:  2015-01-21       Impact factor: 4.677

4.  Computational neurobiology is a useful tool in translational neurology: the example of ataxia.

Authors:  Sherry-Ann Brown; Louise D McCullough; Leslie M Loew
Journal:  Front Neurosci       Date:  2015-01-21       Impact factor: 4.677

5.  Voltage-gated calcium channels: Novel targets for cancer therapy.

Authors:  Nam Nhut Phan; Chih-Yang Wang; Chien-Fu Chen; Zhengda Sun; Ming-Derg Lai; Yen-Chang Lin
Journal:  Oncol Lett       Date:  2017-06-22       Impact factor: 2.967

6.  Next-generation sequencing identifies novel CACNA1A gene mutations in episodic ataxia type 2.

Authors:  Neven Maksemous; Bishakha Roy; Robert A Smith; Lyn R Griffiths
Journal:  Mol Genet Genomic Med       Date:  2016-01-20       Impact factor: 2.183

7.  A Novel CACNA1A Nonsense Variant [c.4054C>T (p.Arg1352)] Causing Episodic Ataxia Type 2.

Authors:  Sean Lance; Stuart Mossman; Gemma Poke
Journal:  Case Rep Neurol Med       Date:  2018-03-11

Review 8.  Episodic Ataxias: Faux or Real?

Authors:  Paola Giunti; Elide Mantuano; Marina Frontali
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.